The centers are using the standardized pipeline to help streamline data sharing and data analysis to achieve their larger research goals.
The deal will grant Myriad entry into the neuroscience space, and will allow it to use Assurex's existing sales force to market its own mental health tests.
The firm plans to launch testing in the US this fall through Atlanta-based Alpha Genomix, and is looking for similar partners in Asia for a new Asia-specific panel.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
The RNA products developer is buying California-based Narus in order to expand into the RNA-based diagnostics market.
Following from genetic studies of compulsive behavior in dogs, researchers have starting collecting behavioral information for dogs in the Darwin's Dogs project.
Researchers tracked one individual's brain imaging patterns, physical features, blood metabolomics, gene expression, and more.
The mental health-focused testing firm plans to use the money to conduct additional studies for Genecept and develop a next-generation product.
The effort will compare the outcomes and healthcare costs of patients whose treatments were informed by genetic testing results against those managed without this information.
Originally published July 28.
Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.
The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.
Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.
In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.